Cargando…
NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15
NR5A2 is a transcription factor regulating the expression of various oncogenes. However, the role of NR5A2 and the specific regulatory mechanism of NR5A2 in pancreatic ductal adenocarcinoma (PDAC) are not thoroughly studied. In our study, Western blotting, real-time PCR, and immunohistochemistry wer...
Autores principales: | Guo, Feng, Zhou, Yingke, Guo, Hui, Ren, Dianyun, Jin, Xin, Wu, Heshui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044179/ https://www.ncbi.nlm.nih.gov/pubmed/33850096 http://dx.doi.org/10.1038/s41420-021-00462-8 |
Ejemplares similares
-
Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer
por: Sun, Yan, et al.
Publicado: (2021) -
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression
por: Sun, Yan, et al.
Publicado: (2023) -
Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL
por: Zhao, Zhiping, et al.
Publicado: (2020) -
USP22‐mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression
por: Ren, Dianyun, et al.
Publicado: (2021) -
The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020)